Moleculin Biotech, Inc.
MBRX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$21,763 | -$29,769 | -$29,025 | -$15,894 |
| Dep. & Amort. | $126 | $127 | $130 | $164 |
| Deferred Tax | $0 | $0 | $0 | -$6,728 |
| Stock-Based Comp. | $1,726 | $1,984 | $2,275 | $2,373 |
| Change in WC | $231 | $1,622 | $224 | $1,038 |
| Other Non-Cash | -$4,182 | $1,935 | -$1,243 | $96 |
| Operating Cash Flow | -$23,862 | -$24,101 | -$27,639 | -$18,951 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$13 | -$124 | -$67 | -$19 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$13 | -$124 | -$67 | -$19 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $4,660 | $4,166 | $0 | $74,684 |
| Stock Repurch. | $0 | $0 | -$23 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$25 | $485 | $0 | $40 |
| Financing Cash Flow | $4,635 | $4,651 | -$23 | $74,724 |
| Forex Effect | -$32 | -$21 | -$29 | -$24 |
| Net Chg. in Cash | -$19,272 | -$19,595 | -$27,758 | $55,730 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $23,550 | $43,145 | $70,903 | $15,173 |
| End Cash | $4,278 | $23,550 | $43,145 | $70,903 |
| Free Cash Flow | -$23,875 | -$24,225 | -$27,706 | -$18,970 |